cysteine has been researched along with sulfasalazine in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.70) | 18.7374 |
| 1990's | 6 (16.22) | 18.2507 |
| 2000's | 12 (32.43) | 29.6817 |
| 2010's | 14 (37.84) | 24.3611 |
| 2020's | 4 (10.81) | 2.80 |
| Authors | Studies |
|---|---|
| Salim, AS | 1 |
| Bird, HA; Dixon, JS; Martin, MF; McKenna, F; Wright, V | 1 |
| Brooks, P; Conaghan, PG | 1 |
| Brooks, P; Conaghan, PG; Girgis, L | 1 |
| Aono, H; Fujisawa, K; Hasunuma, T; Mita, S; Nakajima, T; Nishioka, K; Yamamoto, K | 1 |
| Asano, G; Koda, M; Nakamura, H; Yoshino, S | 1 |
| Murakami, T; Sugita, T; Takata, I; Ueno, M | 1 |
| Hefferton, D; Rahman, P; Robb, D | 1 |
| Asano, G; Nagashima, M; Yoshino, S | 1 |
| Aono, H; Hirano, D; Ishigami, S; Nagashima, M; Sasano, M; Takai, M; Wauke, K; Yoshino, S | 1 |
| Gomita, Y; Kawasaki, Y; Moriyama, M; Shibata, K | 1 |
| Kawabata, D; Mimori, T | 1 |
| Aoyama, M; Asai, K; Fukuoka, M; Kobayashi, M; Kusabe, T; Otsuka, T; Tanikawa, T; Waguri-Nagaya, Y | 1 |
| Hara, M; Inoue, E; Iwatani, M; Kamatani, N; Nakajima, A; Nakamura, T; Tomatsu, T; Yamanaka, H | 1 |
| Nakamura, K; Nakashima, T; Ochi, S; Oda, H; Suematsu, A; Tajiri, Y; Taka, J; Takayanagi, H; Tanaka, S | 1 |
| Matsuda, T; Ohtsubo, H | 1 |
| Yamanaka, H | 1 |
| Mimori, T; Yukawa, N | 1 |
| Abe, M; Kinoshita, M; Nakajima, M; Ohara, H; Ueda, N | 1 |
| Kawai, S; Miyasaka, N; Takeuchi, T; Tanaka, Y; Yamamoto, K | 1 |
| Koyama, Y; Ohta, T; Shiraishi, H; Uchino, A | 1 |
| Amano, H; Kageyama, M; Kempe, K; Kusaoi, M; Matsudaira, R; Matsushita, M; Morimoto, S; Nawata, M; Ogasawara, M; Onuma, S; Sekiya, F; Tada, K; Takasaki, Y; Tamura, N; Toyama, S; Yamaji, K | 1 |
| Ichikawa, N; Yamanaka, H | 1 |
| Kageyama, M; Kempe, K; Kon, T; Kusaoi, M; Matsudaira, R; Matsushita, M; Ogasawara, M; Onuma, S; Sekiya, F; Sugimoto, K; Tada, K; Takasaki, Y; Tamura, N; Yamaji, K | 1 |
| Tamura, N | 1 |
| Tanaka, E; Yamanaka, H | 1 |
| Itoh, K; Liu, T; Maruyama, A; Mimura, J; Ohyama, C; Okada, T; Sato, H; Ye, P | 1 |
| Chen, L; Li, X; Liu, L; Liu, Y; Xue, Y; Yu, B | 1 |
| Abe, C; Funahashi, K; Katayama, K; Kondo, M; Matsubara, T; Matsuno, H; Okada, M; Sagawa, A; Sakai, Y; Yamasaki, K | 1 |
| Ito, S | 1 |
| Albano, R; Lobner, D | 1 |
| Cai, A; Chen, R; Chen, Z; Ganapathy, V; Kou, L; Sun, R; Xiao, S; Yao, Q; Zheng, H; Zheng, Y | 1 |
| Hong, SE; Jang, SK; Jin, HO; Kim, HA; Kim, MR; Noh, WC; Park, IC; Seong, MK | 1 |
| Capelletti, MM; Manceau, H; Peoc'h, K; Puy, H | 1 |
| Nagase, S; Ohta, T; Seino, M; Sendo, K | 1 |
| Adès, L; Alexe, G; Belloucif, Y; Benaksas, C; Berrou, J; Braun, T; Castelli, FA; Chat, L; Chauvel, C; Clappier, E; Dal Bello, R; de Thé, H; Dombret, H; Duchmann, M; Fenaille, F; Fenouille, N; Forget, A; Gardin, C; Huntly, BJ; Itzykson, R; Joudinaud, R; Laiguillon, MC; Ling, F; Lobry, C; Meduri, E; Pacchiardi, K; Pardieu, B; Pasanisi, J; Penneroux, J; Puissant, A; Raffoux, E; Sodaro, G; Stegmaier, K; Su, A; Vaganay, C; Vasseur, L; Wu, HC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
11 review(s) available for cysteine and sulfasalazine
| Article | Year |
|---|---|
Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Cysteine; Drug Therapy, Combination; Gold; Humans; Methotrexate; Penicillamine; Sulfasalazine | 1995 |
Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and penicillamine.
Topics: Age Factors; Antimalarials; Arthritis, Rheumatoid; Clinical Trials as Topic; Cysteine; Digestive System; Gold; Humans; Liver; Methotrexate; Penicillamine; Sulfasalazine | 1994 |
[Disease modifying anti-rheumatic drugs (DMARDs): an overview].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Benzopyrans; Cysteine; Evidence-Based Medicine; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Meta-Analysis as Topic; Methotrexate; Randomized Controlled Trials as Topic; Sulfasalazine; Sulfonamides | 2005 |
[Effective combination therapy of TNF antagonists with DMARDs].
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cysteine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Receptors, Tumor Necrosis Factor; Sulfasalazine; Tumor Necrosis Factor-alpha | 2007 |
[Antirheumatic agents for treatment of rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Methotrexate; Pharmacogenetics; Randomized Controlled Trials as Topic; Remission Induction; Sulfasalazine; Time Factors | 2008 |
[Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Cysteine; Disease Progression; Drug Therapy, Combination; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Methotrexate; Penicillamine; Radiography; Randomized Controlled Trials as Topic; Sulfasalazine; Tacrolimus | 2009 |
[ Bone and cartilage destruction in RA and its intervention. Disease-modifying antirheumatic drugs].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Bone and Bones; Cartilage; Clinical Trials as Topic; Cysteine; Humans; Isoxazoles; Joints; Leflunomide; Methotrexate; Sulfasalazine; Tacrolimus | 2012 |
[DMARDs (disease-modifying antirheumatic drugs)].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Humans; Japan; Methotrexate; Sulfasalazine; Tacrolimus | 2013 |
[DMARDs (Focusing on iguratimod)].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Cysteine; Drug Discovery; Drug Interactions; Drug Substitution; Drug Therapy, Combination; Drugs, Generic; Female; Humans; Male; Ribonucleosides; Sulfasalazine; Sulfonamides; Tacrolimus | 2016 |
Ferroptosis in Liver Diseases: An Overview.
Topics: alpha-Tocopherol; Animals; Autophagy; Chemical and Drug Induced Liver Injury; Cyclohexylamines; Cysteine; Ferroptosis; Glutathione; Heme; Humans; Iron; Kelch-Like ECH-Associated Protein 1; Lipid Peroxidation; Lipoxygenase; Liver Diseases; Liver Neoplasms; Oxidative Stress; Phenylenediamines; Phospholipid Hydroperoxide Glutathione Peroxidase; Piperazines; Quinoxalines; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction; Sorafenib; Spiro Compounds; Sulfasalazine; Tumor Suppressor Protein p53 | 2020 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for cysteine and sulfasalazine
| Article | Year |
|---|---|
Role of sulphydryl-containing agents in the management of recurrent attacks of ulcerative colitis. A new approach.
Topics: Adult; Aged; Anti-Ulcer Agents; Colitis, Ulcerative; Cysteine; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prednisolone; Prospective Studies; Recurrence; Sulfasalazine; Sulfhydryl Compounds; Vitamin U | 1992 |
Efficacy profile of bucillamine in rheumatoid arthritis patients in a large observational cohort study, IORRA.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cohort Studies; Cysteine; Drug Therapy, Combination; Female; Health Status; Humans; Joints; Male; Methotrexate; Middle Aged; Pain; Prednisolone; Prospective Studies; Remission Induction; Severity of Illness Index; Sulfasalazine | 2006 |
A comparative study of the effects of bucillamine and salazosulfapyridine in the treatment of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Cysteine; Drug Therapy, Combination; Female; Hand Strength; Health Status; Humans; Joints; Male; Middle Aged; Pain; Prednisolone; Severity of Illness Index; Sulfasalazine; Time Factors; Treatment Outcome | 2009 |
Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs--a multicenter, double-blind, parallel-group trial.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Joints; Male; Methotrexate; Middle Aged; Severity of Illness Index; Sulfasalazine; Tacrolimus; Treatment Outcome | 2011 |
22 other study(ies) available for cysteine and sulfasalazine
| Article | Year |
|---|---|
Biochemical and clinical changes occurring during the treatment of rheumatoid arthritis with novel antirheumatoid drugs.
Topics: Adult; Aged; Arthritis, Rheumatoid; Blood Viscosity; Captopril; Cysteine; Female; Humans; Male; Middle Aged; Penicillamine; Sulfasalazine; Sulfates; Zinc; Zinc Sulfate | 1985 |
Direct suppression of human synovial cell proliferation in vitro by salazosulfapyridine and bucillamine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Base Sequence; Cell Division; Cells, Cultured; Cysteine; Drug Combinations; Humans; Interleukins; Models, Biological; Molecular Sequence Data; Sulfasalazine; Synovial Membrane | 1996 |
[Effects of disease modifying antirheumatic drugs (DMARDs) and DEX on IL-1 beta and IL-6 production by IL-1 beta stimulated synovial culture cells].
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Cells, Cultured; Cysteine; Depression, Chemical; Dexamethasone; Gold Sodium Thiomalate; Humans; Interleukin-1; Interleukin-6; Methotrexate; Ribonucleosides; Sulfasalazine; Synovial Membrane; Tumor Necrosis Factor-alpha | 1996 |
The novel anti-rheumatic drug TA-383 has a macrophage migration enhancing activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Reactive; Cell Movement; Chemotactic Factors; Collagen; Cysteine; Hypersensitivity, Delayed; Imidazoles; In Vitro Techniques; Macrophages, Alveolar; Mice; Mice, Inbred DBA; ortho-Aminobenzoates; Picryl Chloride; Rabbits; Sulfasalazine | 1997 |
Increased MDR1 P-glycoprotein expression in methotrexate resistance: comment on the article by Yudoh et al.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cysteine; Drug Interactions; Drug Resistance, Multiple; Humans; Methotrexate; Sulfasalazine; Th1 Cells | 2000 |
Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Collagen; Cysteine; Drug Therapy, Combination; Endostatins; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factor 2; Humans; Lymphokines; Middle Aged; Osteoarthritis; Peptide Fragments; Prednisolone; Sulfasalazine; Synovial Fluid; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Cells, Cultured; Cysteine; Dexamethasone; Drug Synergism; Drug Therapy, Combination; Endothelial Growth Factors; Fibroblast Growth Factor 2; Gold Sodium Thiomalate; Humans; In Vitro Techniques; Lipopolysaccharides; Lymphokines; Methotrexate; Sulfasalazine; Synovial Membrane; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
[Examination of the escape phenomenon in disease modifying antirheumatic drugs].
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Cysteine; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Phenylacetates; Recurrence; Secondary Prevention; Sulfasalazine | 2005 |
The inhibitory effect of disease-modifying anti-rheumatic drugs and steroids on gliostatin/platelet-derived endothelial cell growth factor production in human fibroblast-like synoviocytes.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cells; Cells, Cultured; Cysteine; Dexamethasone; Elbow; Female; Fibroblasts; Humans; Knee; Methotrexate; Middle Aged; Organogold Compounds; Orthopedic Procedures; Penicillamine; Phenylacetates; Sulfasalazine; Synovial Membrane; Thymidine Phosphorylase | 2005 |
Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Resorption; Cell Differentiation; Cells, Cultured; Coculture Techniques; Cysteine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Methotrexate; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Osteoclasts; RANK Ligand; Sulfasalazine | 2007 |
Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Drug Substitution; Drug Therapy, Combination; Etanercept; Female; Glucocorticoids; Humans; Immunoglobulin G; Joints; Male; Methotrexate; Middle Aged; Pain Measurement; Receptors, Tumor Necrosis Factor; Recovery of Function; Retrospective Studies; Severity of Illness Index; Sulfasalazine; Treatment Failure | 2012 |
Single-center, retrospective analysis of efficacy and safety of tacrolimus as a second-line DMARD in combination therapy and the risk factors contributing to adverse events in 115 patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Disease Progression; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Sulfasalazine; Tacrolimus; Treatment Outcome | 2012 |
Recent trends in use of nonbiologic DMARDs and evaluation of their continuation rates in single and dual combination therapies in rheumatoid arthritis patients in Japan.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Drug Therapy, Combination; Female; Humans; Japan; Male; Methotrexate; Practice Patterns, Physicians'; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2012 |
[Rheumatoid arthritis: progress in diagnosis and treatment. Topics: IV. Treatment; 2. Antirheumatic agents, 1) non-biologic agents].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Female; Humans; Methotrexate; Sulfasalazine; Tacrolimus | 2012 |
Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition.
Topics: Activating Transcription Factor 4; Amino Acid Transport System y+; Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Line, Tumor; Cysteine; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glutathione; Glycine; HEK293 Cells; HeLa Cells; Humans; Leupeptins; NF-E2-Related Factor 2; Oligopeptides; Proteasome Endopeptidase Complex; Pyrazines; RNA, Small Interfering; Sulfasalazine; Urinary Bladder Neoplasms | 2014 |
Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function.
Topics: Amino Acid Transport System y+; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biological Transport; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cystathionine gamma-Lyase; Cysteine; Dacarbazine; Drug Resistance, Neoplasm; Enzyme Activation; Glioblastoma; Glutathione; Humans; NF-E2-Related Factor 2; Piperazines; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Sulfasalazine; Temozolomide | 2015 |
The usefulness of a new triple combination treatment utilizing methotrexate, salazosulfapyridine, and bucillamine in rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Cysteine; Drug Therapy, Combination; Female; Humans; Japan; Male; Methotrexate; Middle Aged; Sulfasalazine; Treatment Outcome | 2016 |
Transport of BMAA into Neurons and Astrocytes by System x
Topics: Amino Acid Transport Systems; Amino Acids, Diamino; Animals; Aspartic Acid; Astrocytes; Carbon Isotopes; Cells, Cultured; Cerebral Cortex; Cyanobacteria Toxins; Cysteine; Embryo, Mammalian; Female; Glutamic Acid; Glutathione; Mice; Neurons; Neurotransmitter Uptake Inhibitors; Pregnancy; Sulfasalazine; Time Factors | 2018 |
Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy.
Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cysteine; Cystine; Glutathione; Humans; Nanoparticles; Neoplasms; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Sulfasalazine; Zinc Oxide | 2019 |
Hypoxia Suppresses Cysteine Deprivation-induced Cell Death
Topics: Activating Transcription Factor 4; Breast Neoplasms; Cell Death; Cell Hypoxia; Cell Line, Tumor; Cysteine; Female; Humans; Sulfasalazine; Transfection; Up-Regulation | 2020 |
Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer.
Topics: Amino Acid Transport System y+; Antioxidants; Antiporters; Carcinoma, Endometrioid; Cell Line, Tumor; Cisplatin; Cystathionine gamma-Lyase; Cysteine; Cystine; Female; Glutathione; Humans; Methionine; Reactive Oxygen Species; Sulfasalazine | 2022 |
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.
Topics: Cell Line, Tumor; Cysteine; Cystine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Nuclear Proteins; Sulfasalazine | 2022 |